DISULFIRAM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for disulfiram and what is the scope of freedom to operate?
Disulfiram
is the generic ingredient in two branded drugs marketed by Odyssey Pharms, Teva Womens, Alvogen, Chartwell Molecules, Dash Pharms, Hikma, Sigmapharm Labs Llc, Strides Pharma, Watson Labs, and Watson Labs Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for disulfiram. Four suppliers are listed for this compound.
Summary for DISULFIRAM
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 10 |
NDAs: | 14 |
Drug Master File Entries: | 7 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 67 |
Patent Applications: | 6,356 |
Drug Prices: | Drug price trends for DISULFIRAM |
What excipients (inactive ingredients) are in DISULFIRAM? | DISULFIRAM excipients list |
DailyMed Link: | DISULFIRAM at DailyMed |
Recent Clinical Trials for DISULFIRAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University | N/A |
College of Pharmaceutical Sciences at Zhejiang University | N/A |
First People's Hospital of Hangzhou | N/A |
Pharmacology for DISULFIRAM
Drug Class | Aldehyde Dehydrogenase Inhibitor |
Mechanism of Action | Acetyl Aldehyde Dehydrogenase Inhibitors |
Medical Subject Heading (MeSH) Categories for DISULFIRAM
Anatomical Therapeutic Chemical (ATC) Classes for DISULFIRAM
US Patents and Regulatory Information for DISULFIRAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | DISULFIRAM | disulfiram | TABLET;ORAL | 202652-002 | Feb 5, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | DISULFIRAM | disulfiram | TABLET;ORAL | 087973-001 | Aug 5, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | DISULFIRAM | disulfiram | TABLET;ORAL | 087974-001 | Aug 5, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | DISULFIRAM | disulfiram | TABLET;ORAL | 086889-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.